Literature DB >> 9772021

Comparison of pathological diagnostic criteria for Alzheimer disease.

Z s Nagy1, M M Esiri, C Joachim, K A Jobst, J H Morris, E M King, N J Hindley, B McDonald, S Litchfield, L Barnetson, A D Smith.   

Abstract

Because the clinical picture of Alzheimer disease (AD) is often difficult to discriminate from other dementing illnesses, the diagnosis of AD requires neuropathological confirmation. However, for the pathological diagnosis of AD, there are no unanimously accepted criteria. The three currently used sets of pathological criteria (Khachaturian: Khachaturian, Arch Neurol 1985;42:1097-105; Tiemy: Tierney et al., Can J Neurol Sci 1986; 13:424-6; CERAD: Mirra et al., Neurology 1991;41:479-86) for the disease differ from each other considerably. We applied these criteria to the first 43 consecutive subjects (37 demented) with no neuropathology other than AD-type pathology from autopsies after longitudinal prospective clinical study in the Oxford Project to Investigate Memory and Ageing (OPTIMA). The results show that the CERAD category of definite AD corresponds closely with the cases that fulfill Tierney A3 inclusion criteria for AD. The combined CERAD categories of possible, probable, and definite AD correspond closely to cases fulfilling Khachaturian criteria forAD. The influence of a clinical diagnosis of dementia when Khachaturian and CERAD criteria were applied was considerable because between 9.3% and 90.7% of patients would have been categorized differently depending on whether clinical dementia was present or absent.

Entities:  

Mesh:

Year:  1998        PMID: 9772021     DOI: 10.1097/00002093-199809000-00010

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  8 in total

1.  Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Edward Re; Lisa Longato; Ming Tong
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.

Authors:  Michael D Hoos; Brenna M Richardson; Matthew W Foster; Angela Everhart; J Will Thompson; M Arthur Moseley; Carol A Colton
Journal:  J Proteome Res       Date:  2013-09-18       Impact factor: 4.466

3.  T(1ρ) MRI in Alzheimer's disease: detection of pathological changes in medial temporal lobe.

Authors:  Mohammad Haris; Anup Singh; Kejia Cai; Erin McArdle; Matthew Fenty; Christos Davatzikos; John Q Trojanowski; Elias R Melhem; Christopher M Clark; Arijitt Borthakur
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

4.  MICEST: a potential tool for non-invasive detection of molecular changes in Alzheimer's disease.

Authors:  Mohammad Haris; Anup Singh; Kejia Cai; Kavindra Nath; Rachelle Crescenzi; Feliks Kogan; Hari Hariharan; Ravinder Reddy
Journal:  J Neurosci Methods       Date:  2012-10-03       Impact factor: 2.390

5.  Crucial role of calbindin-D28k in the pathogenesis of Alzheimer's disease mouse model.

Authors:  S-Y Kook; H Jeong; M J Kang; R Park; H J Shin; S-H Han; S M Son; H Song; S H Baik; M Moon; E C Yi; D Hwang; I Mook-Jung
Journal:  Cell Death Differ       Date:  2014-05-23       Impact factor: 15.828

6.  Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.

Authors:  Jacob A Irwin; Alev Erisir; Inchan Kwon
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2.

Authors:  Donna M Wilcock; Matthew R Lewis; William E Van Nostrand; Judianne Davis; Mary Lou Previti; Nastaran Gharkholonarehe; Michael P Vitek; Carol A Colton
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

8.  Disruption of blood-brain barrier in Alzheimer disease pathogenesis.

Authors:  Sun-Young Kook; Hyun Seok Hong; Minho Moon; Inhee Mook-Jung
Journal:  Tissue Barriers       Date:  2013-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.